A Florida judge has cleared the way for prosecutors to obtain Tiger Woods' prescription medication records, handing the state a key piece of evidence in its DUI case against the golf legend and dealing his defense team a loss in a privacy fight that could shape the trial's outcome.
The ruling allows Martin County prosecutors to subpoena records from Lewis Pharmacy in Palm Beach covering January 1 through March 27, 2026, the date of Woods' arrest. The records will include prescription fill dates, pill counts, dosage amounts, refill history, and any warnings about operating a motor vehicle while taking the medications, Breitbart reported.
Woods pleaded not guilty to misdemeanor DUI with property damage following a rollover crash on Jupiter Island, Florida. He blew 0.00 on a breathalyzer at the scene, meaning alcohol played no apparent role. But deputies noted signs of impairment, including lethargic movements, and Woods told them he takes prescription medications tied to his extensive surgical history.
With alcohol ruled out by the breathalyzer, the prosecution's case hinges on proving Woods was impaired by something else. That makes his prescription drug history central to the state's theory. Prosecutors will likely pair the pharmacy records with field sobriety test results and officer observations from the night of the arrest to build their case, AP News reported.
Woods' defense had argued he held a constitutional privacy right over his prescription records. His attorneys did not dispute that the right was limited, but they pushed back on the scope of the state's request. The judge ultimately sided with prosecutors, approving an agreement that includes a protective order. That order restricts access to the records to prosecutors, law enforcement, state-retained experts, and Woods' own defense team.
CLN previously covered the prosecutors' initial push to crack open those records, which set the stage for the ruling now handed down.
Bob Jarvis, a law professor at Nova Southeastern University, told AP News that the ruling should not surprise anyone familiar with Florida DUI procedure. He framed it as routine rather than celebrity-driven.
"We don't know if the prosecutor offered a plea, and a typical defendant would have taken the plea, and Tiger Woods decided not to take the plea. But other than that, I think that this is what would happen no matter who the defendant was."
That observation cuts both ways. If the process is standard, Woods cannot credibly claim he is being singled out. But it also means the state is not giving him any special treatment, either. The law is moving forward on the same track it would for any driver found slumped behind the wheel after a single-vehicle crash.
Woods was arrested on March 27 after a rollover crash on Jupiter Island. Deputies who responded to the scene described him as showing signs of impairment despite the clean breathalyzer reading. Court filings indicate he refused additional drug testing at the time of the arrest.
The refusal matters. In Florida, refusing a chemical test after a lawful DUI arrest can carry its own administrative penalties and can also be introduced at trial as consciousness of guilt. Prosecutors now appear to be building an alternative evidentiary path through the pharmacy records, sidestepping the gap left by the refused test.
Woods told deputies at the scene that he takes prescription medications connected to his well-documented history of back and leg surgeries. That admission, combined with the triple-zero breathalyzer, likely gave prosecutors the factual basis they needed to argue the pharmacy records were relevant and not a fishing expedition.
Shortly after the arrest, Woods released a public statement acknowledging the gravity of his situation.
"I know and understand the seriousness of the situation I find myself in today. I am stepping away for a period of time to seek treatment and focus on my health."
His attorney later told the court that Woods needed an "intensive, highly individualized and medically integrated program" away from media and public scrutiny, Newsmax reported. Woods has since left competitive golf temporarily to pursue that treatment.
The statement stops short of any admission of wrongdoing. But it signals that Woods and his legal team recognize the case carries real consequences, both in the courtroom and for his public standing.
Misdemeanor DUI with property damage in Florida can carry penalties including fines, probation, community service, license suspension, and even jail time. For a first offense, incarceration is unlikely but not impossible, particularly if prosecutors can show the level of impairment was severe.
The pharmacy records will give the state a detailed picture of what Woods was prescribed, how often he filled those prescriptions, and whether any of the medications carried explicit warnings against driving. If any medication was filled in quantities or on a schedule that suggests misuse, prosecutors could use that to bolster their impairment theory. If the records show routine, properly managed prescriptions, the defense will argue the medications alone do not prove Woods was impaired at the time of the crash.
High-profile impaired driving cases often draw intense public attention to how the justice system treats celebrities versus ordinary defendants. Justin Timberlake's 2024 arrest in Sag Harbor raised similar questions about equal treatment and public accountability when fame enters the courtroom.
Investigators have not publicly confirmed whether they recovered any medications from Woods' vehicle or person at the time of the crash. Prosecutors have also not disclosed what specific substances, if any, they believe caused the impairment. Those details may emerge as the case moves closer to trial or as the pharmacy records are reviewed under the protective order.
The broader question of how prescription drug use intersects with public safety enforcement continues to surface across multiple areas of law. Federal regulators have pursued enforcement actions against airlines over drug and alcohol testing failures, reflecting a growing institutional focus on substance-related impairment beyond the highway context.
With the judge's ruling in hand, prosecutors can now move to subpoena the Lewis Pharmacy records. The protective order means the public will not see the raw prescription data unless it is introduced at trial or referenced in open court filings. Woods' defense team will have access to the same records and can challenge their relevance or interpretation before a jury.
No trial date has been publicly set. The next procedural steps will likely involve motions over what evidence can be admitted, how the pharmacy records can be used, and whether any expert testimony on pharmacology will be allowed.
Woods faces a straightforward legal reality: a clean breathalyzer kept alcohol off the table, but it also pushed prosecutors toward his medicine cabinet. The court just opened the door, and the state intends to walk through it.
